ADVANCES IN THERAPY, vol.25, no.6, pp.552-566, 2008 (Peer-Reviewed Journal)
Article / Article
ADVANCES IN THERAPY
Science Citation Index Expanded, Scopus
Introduction: The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once daily (q.d.) in healing reflux oesophagitis at 4 and 8 weeks, and the efficacy of esomeprazole 20 mg q.d. for 12 weeks in the maintenance of remission.